Twenty years ago, Roger Cone, Ph.D., made a key discovery in obesity science which could help Courage Therapeutics deliver products that improve upon currently available treatments for obesity.
Inclusion bodies, which are typically undesirable, are now gaining attention for their potential to produce a range of difficult-to-express proteins in E. coli systems.
Middlesex County, NJ, offers life sciences organizations a deep talent pool, an extensive R&D presence, and dedicated backing by local government investment.
Project SHASTA, a pioneering effort to measure the benefits of decentralized trial elements, reveals significant regulatory opportunities that could shape the future of clinical research.
Discover how an empty building shell became a sustainable nanomedicine hub and achieved 47% energy savings and 88% fewer emissions, which sets new standards for innovation in the biologics industry.
Explore what makes licensing and localization so onerous, and find solutions to typical challenges so study teams can confidently mitigate risks to meet aggressive timelines.
Timely and effective patient recruitment remains one of the greatest challenges in clinical research, with success depending on optimizing patient quality and sustained engagement support.
